Healthcare Marijuana, Inc. Subsidiary Kannaway® Starts Recruiting CBD Customers for ValidCare Virtual Study(TM)

green grass

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — by means of NEWMEDIAWIRE — Healthcare Marijuana, Inc. (OTC: MJNA) (the “Organization”), the 1st-ever publicly traded cannabis firm in the United States that launched the world’s 1st-ever cannabis-derived nutraceutical solutions, brands and provide chain, announced right now that its subsidiary Kannaway® has begun recruiting cannabidiol (CBD) customers to participate in the ValidCare CBD security study. The nationwide observational study is applying its solutions to measure the prospective effects on the liver of orally consumed, hemp-derived CBD solutions in wholesome adults. Participants will supply actual-time feedback by means of ValidCare’s Virtual Study&#x2122 platform and provide blood samples for evaluation as portion of the study.

“Since day 1, we have been devoted to offering our shoppers with secure, constant solutions they can trust,” mentioned Healthcare Marijuana, Inc. CEO Dr. Stuart Titus. “This study assists us additional that commitment and lets us take portion in an sector work to supply additional proof that CBD holds lots of wellness rewards without having damaging side effects.”

The IRB-authorized study, which was created to respond to the FDA’s lots of requests for science-primarily based information, is becoming performed by ValidCare and qualifies as a national clinical trial. Kannaway® is 1 of 13 sector-top providers to participate and enable the FDA identify the regulatory path for hemp-derived CBD solutions. Each and every firm is accountable for offering lot-distinct solution data for the study and recruiting a target of one hundred shoppers to participate. Upon completion of the study, Kannaway will obtain security information pertaining to these distinct participants. Buyers are screened to assure they meet study criteria ahead of they are authorized and enrolled. Participants will use Kannaway hemp-derived CBD or CBD isolate solutions for 30 consecutive days and supply a blood sample. More than 1,000 shoppers have expressed interest in becoming portion of the study.

“It’s encouraging to see the CBD sector functioning with each other to additional CBD study,” mentioned Kannaway® CEO Blake Schroeder. “We invest drastically in scientific study, like internal and external independent research such as ValidCare’s simply because it is crucial to gaining customer trust.”

Benefits of the study will be shared with the FDA and are anticipated to be published in a peer-reviewed journal in early 2021.

To discover much more about the study please check out https://validcare.com/validcare-national-cbd-liver-function-study/.

About ValidCare

ValidCare, LLC supplies contract study outsourcing (CRO) and virtual study options for life sciences and customer packaged goods industries. ValidCare’s proprietary platform supports decentralized, hybrid and virtual study powered by actual globe proof (RWE) to provide insights that enable fuel healthier generations. For much more data, check out www.validcare.com or contact 844-825-4322.

About Kannaway
Kannaway® is a network sales and advertising and marketing firm specializing in the sales and advertising and marketing of hemp-primarily based botanical solutions. Kannaway® at the moment hosts weekly on line sales meetings and conferences across the United States, providing distinctive insight and chance to sales pros who are desirous of becoming effective leaders in the sale and advertising and marketing of hemp-primarily based botanical solutions.

About Healthcare Marijuana, Inc.
We are a firm of firsts®. Healthcare Marijuana, Inc. (MJNA) is a cannabis firm with 3 distinct business enterprise units in the non-psychoactive cannabinoid space: a international portfolio of cannabinoid-primarily based nutraceutical brands led by Kannaway® and HempMeds® a pioneer in sourcing the highest-high quality legal non-psychoactive cannabis solutions derived from industrial hemp and a cannabinoid-primarily based clinical study and botanical drug improvement sector led by its pharmaceutical investment providers and partners like AXIM® Biotechnologies, Inc. and Kannalife, Inc. Healthcare Marijuana, Inc. was named a top rated CBD producer by CNBC. Healthcare Marijuana, Inc. was also the 1st firm to obtain historic import permits for CBD solutions from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the improvement of international markets. The company’s flagship solution Genuine Scientific Hemp Oil has been utilised in many effective clinical research all through Mexico and Brazil to comprehend its security and efficacy.

Healthcare Marijuana, Inc.’s headquarters is in San Diego, California, and extra data is obtainable at OTCMarkets.com or by going to www.medicalmarijuanainc.com. To see Healthcare Marijuana, Inc.’s corporate video, click right here.

Shareholders and shoppers are also encouraged to acquire CBD oil and other solutions at Healthcare Marijuana, Inc.’s shop.

FORWARD-Seeking DISCLAIMER
This press release may well include specific forward-seeking statements and data, as defined inside the which means of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is topic to the Secure Harbor designed by these sections. This material includes statements about anticipated future events and/or economic benefits that are forward-seeking in nature and topic to dangers and uncertainties. Such forward-seeking statements by definition involve dangers, uncertainties and other variables, which may well result in the actual benefits, overall performance or achievements of Healthcare Marijuana, Inc. to be materially diverse from the statements produced herein.

Meals AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Meals and Drug Administration. This solution is not intended to diagnose, treat, remedy, or stop any illness.

LEGAL DISCLOSURE
Healthcare Marijuana, Inc. does not sell or distribute any solutions that are in violation of the United States Controlled Substances Act.

Speak to:

Public Relations Speak to:
Andrew Really hard
Chief Executive Officer
CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

Investor Relations Speak to:
P. (858) 283-4016
[email protected]

Primary Logo

If You Liked This Report Click To Share

.mobile_tx{show: none}
#ax1x{
font-size: 1.1em
font-weight: bold
line-height: 1.five
clear:each
margin: 0px 0px 20px 1% !essential
min-height: four.5em
text-transform: uppercase
padding: .25em 10px
position: relative
width: 98%
float: left
}
.subsequent-pg {
height: 85px !essential
width: one hundred%
border-top rated-left-radius: 3px
border-bottom-left-radius: 3px
background-colour: #e5192c
background-image: url(‘/wp-content material/themes/mh-magazine/photos/international-immediately after.png’) !essential
background-repeat: no-repeat
background-position: proper center
background-size: auto one hundred%
overflow: hidden
box-sizing: border-box
margin-bottom: 0px
margin-top rated: 10px
position: relative
padding-left: 100px
}
.subsequent-pg::ahead of {
width: 45px !essential
height: 85px !essential
show: block
content material: “”
width: 32px
height: 64px
background-image: url(‘/wp-content material/themes/mh-magazine/photos/international-ahead of.png’) !essential
background-repeat: no-repeat
background-position: proper center
background-size: auto one hundred%
position: absolute
left: -4px
top rated: 0px
}
.action-txt {
text-transform: uppercase
margin: 12px
line-height: 61px
text-align: left
font-size: 36px
background-repeat: no-repeat
background-position: proper center
background-size: 26px 18px
colour: #FFF
float: left
font-weight: bold
font-loved ones: “Open Sans”,sans-serif !essential
width: 78%
show: inline-block
text-align: center
}
@media (max-width: 768px){
.mobile_tx{show: block}
.desktop_tx{show: none}
.pps-slider-nav .pps-subsequent {
text-align: center
position: static
padding: 5px 20px
float: left
width: one hundred%
box-sizing: border-box
}
.pps-subsequent .subsequent-post-web page {
padding-left:
float: left
margin:
}
.subsequent-post-web page .action-txt {
padding-left: !essential
text-align: center
width: 87%
box-sizing: border-box
font-size: 26px
background:
text-align: center
}
#ax1x {
padding: .25em !essential
min-height: two.3em
width: one hundred% !essential
margin: 0px !essential
margin-bottom: 15px !essential
padding-bottom: !essential
}
}
@media (max-width: 500px){
.subsequent-post-web page .action-txt{
width: 75%
}
}

Latest posts